{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T20:59:21Z","timestamp":1793134761048,"version":"4.5.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1016\/j.clinthera.2015.04.008","type":"journal-article","created":{"date-parts":[[2015,5,15]],"date-time":"2015-05-15T04:37:34Z","timestamp":1431664654000},"page":"1443-1453.e2","source":"Crossref","is-referenced-by-count":41,"title":["Clinical Outcomes of Daptomycin for Vancomycin-resistant Enterococcus Bacteremia"],"prefix":"10.1016","volume":"37","author":[{"given":"Pamela A.","family":"Moise","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Sakoulas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James A.","family":"McKinnell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth C.","family":"Lamp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daryl D.","family":"DePestel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min J.","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Reyes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus J.","family":"Zervos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2015.04.008_bib1","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.diagmicrobio.2006.12.022","article-title":"Antimicrobial resistance and molecular epidemiology of vancomycin-resistant enterococci from North America and Europe: a report from the SENTRY antimicrobial surveillance program","volume":"58","author":"Deshpande","year":"2007","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.clinthera.2015.04.008_bib2","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1086\/593956","article-title":"Secular trends of hospitalization with vancomycin-resistant enterococcus infection in the United States, 2000-2006","volume":"30","author":"Ramsey","year":"2009","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.clinthera.2015.04.008_bib3","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1086\/519932","article-title":"Outcomes for and risk factors associated with vancomycin-resistant Enterococcus faecalis and vancomycin-resistant Enterococcus faecium bacteremia in cancer patients","volume":"28","author":"Ghanem","year":"2007","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.clinthera.2015.04.008_bib4","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1086\/427512","article-title":"Impact of vancomycin resistance on mortality among patients with neutropenia and enterococcal bloodstream infection","volume":"191","author":"Diaz-Granados","year":"2005","journal-title":"J Infect Dis"},{"key":"10.1016\/j.clinthera.2015.04.008_bib5","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1111\/j.1399-0012.2005.00362.x","article-title":"Consequences of vancomycin-resistant Enterococcus in liver transplant recipients: a matched control study","volume":"19","author":"Gearhart","year":"2005","journal-title":"Clin Transplant"},{"key":"10.1016\/j.clinthera.2015.04.008_bib6","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1007\/s00520-010-1038-z","article-title":"Outcomes of therapy: vancomycin-resistant enterococcal bacteremia in hematology and bone marrow transplant patients","volume":"19","author":"Kraft","year":"2011","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.clinthera.2015.04.008_bib7","doi-asserted-by":"crossref","first-page":"5013","DOI":"10.1128\/AAC.00714-13","article-title":"Systematic review and meta-analysis of linezolid versus daptomycin for treatment of vancomycin-resistant enterococcal blood stream infections","volume":"57","author":"Whang","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.clinthera.2015.04.008_bib8","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1093\/cid\/ciq113","article-title":"Daptomycin nonsusceptible enterococci: an emerging challenge for clinicians","volume":"52","author":"Kelesidis","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.clinthera.2015.04.008_bib9","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1093\/cid\/ciu642","article-title":"Failure of high-dose daptomycin for bacteremia caused by daptomycin-susceptible Enterococcus faecium harboring LiaSR substitutions","volume":"59","author":"Munita","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.clinthera.2015.04.008_bib10","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1093\/jac\/dkr255","article-title":"Vancomycin-resistant Enterococcal bacteremia and daptomycin: are higher doses necessary?","volume":"66","author":"King","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.clinthera.2015.04.008_bib11","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1128\/AAC.05551-11","article-title":"Ampicillin enhances daptomycin- and cationic host defense peptide-mediate killing of ampicillin and vancomycin-resistant Enterococcus faecium","volume":"56","author":"Sakoulas","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.clinthera.2015.04.008_bib12","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1016\/j.amjmed.2007.07.008","article-title":"Cubicin Outcomes Registry and Experience (CORE) methodology","volume":"120","author":"Rolston","year":"2007","journal-title":"Am J Med"},{"key":"10.1016\/j.clinthera.2015.04.008_bib13","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1086\/502196","article-title":"Effect of nosocomial vancomycin-resistant enterococcal bacteremia on mortality, length of stay, and costs","volume":"24","author":"Song","year":"2003","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.clinthera.2015.04.008_bib14","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1086\/430909","article-title":"Comparison of mortality associated with vancomycin-resistant and vancomycin-susceptible enterococcal bloodstream infections: a meta-analysis","volume":"41","author":"Diaz-Granados","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.clinthera.2015.04.008_bib15","unstructured":"National Center for Preparedness, Detection, and Control of Infectious Diseases (U.S.), Division of Healthcare Quality Promotion. The direct medical costs of healthcare-associated infections in U.S. hospitals and the benefits of prevention. http:\/\/stacks.cdc.gov\/view\/cdc\/11550\/. Accessed 23 August 2013."},{"key":"10.1016\/j.clinthera.2015.04.008_bib16","doi-asserted-by":"crossref","first-page":"484","DOI":"10.7326\/0003-4819-135-7-200110020-00007","article-title":"Determinants of vancomycin resistance and mortality rates in enterococcal bacteremia. a prospective multicenter study","volume":"135","author":"Vergis","year":"2001","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.clinthera.2015.04.008_bib17","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1086\/523588","article-title":"Impact of the more-potent antibiotics quinupristin-dalfopristin and linezolid on outcome measure of patients with vancomycin-resistant Enterococcus bacteremia","volume":"46","author":"Erlandson","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.clinthera.2015.04.008_bib18","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/j.1469-0691.2010.03214.x","article-title":"Management of multidrug-resistant enterococcal infections","volume":"16","author":"Arias","year":"2010","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.clinthera.2015.04.008_bib19","doi-asserted-by":"crossref","first-page":"6051","DOI":"10.1128\/AAC.01318-12","article-title":"Genotypic and phenotypic evaluation of the evolution of high-level daptomycin non-susceptibility in vancomycin-resistant Enterococcus faecium","volume":"56","author":"Humphries","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.clinthera.2015.04.008_bib20","doi-asserted-by":"crossref","first-page":"4494","DOI":"10.1128\/JB.00011-12","article-title":"Daptomycin-mediated reorganization of membrane architecture causes mislocalization of essential cell division proteins","volume":"194","author":"Pogliano","year":"2012","journal-title":"J Bacteriol"},{"issue":"4","key":"10.1016\/j.clinthera.2015.04.008_bib21","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00281-13","article-title":"Daptomycin-resistant Enterococcus faecalis diverts the antibiotic molecule from the division septum and remodels cell membrane phospholipids","volume":"4","author":"Tran","year":"2013","journal-title":"MBio"},{"key":"10.1016\/j.clinthera.2015.04.008_bib22","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1128\/AAC.02274-13","article-title":"Ceftaroline restores daptomycin activity of daptomycin-resistant vancomycin-resistant Enterococcus faecium","volume":"58","author":"Sakoulas","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.clinthera.2015.04.008_bib23","doi-asserted-by":"crossref","first-page":"4354","DOI":"10.1128\/AAC.00509-12","article-title":"Correlation between mutations in liaFSR of Enterococcus faecium and MIC of daptomycin: revisiting daptomycin breakpoints","volume":"56","author":"Munita","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.clinthera.2015.04.008_bib24","doi-asserted-by":"crossref","first-page":"3424","DOI":"10.1128\/AAC.00356-06","article-title":"Role of vraRS in antibiotic resistance and antibiotic-induced stress response in Staphylococcus aureus","volume":"50","author":"Gardete","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.clinthera.2015.04.008_bib25","doi-asserted-by":"crossref","first-page":"2831","DOI":"10.1128\/AAC.00021-13","article-title":"A liaF codon deletion abolishes daptomycin bactericidal activity against vancomycin-resistant Enterococcus faecalis","volume":"57","author":"Munita","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.clinthera.2015.04.008_bib26","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1086\/522656","article-title":"Failure of daptomycin monotherapy for endocarditis caused by an Enterococcus faecium strain with vancomycin-resistant and vancomycin-susceptible subpopulations and evidence of in vivo loss of the vanA gene cluster","volume":"45","author":"Arias","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.clinthera.2015.04.008_bib27","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1056\/NEJMoa1011138","article-title":"Genetic basis for in vivo daptomycin resistance in enterococci","volume":"365","author":"Arias","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinthera.2015.04.008_bib28","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.ijantimicag.2009.12.022","article-title":"In vitro prevention of the emergence of daptomycin resistance in Staphylococcus aureus and enterococci following combination with amoxicillin\/clavulanic acid or ampicillin","volume":"35","author":"Entenza","year":"2010","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.clinthera.2015.04.008_bib29","doi-asserted-by":"crossref","first-page":"5046","DOI":"10.1128\/AAC.00502-12","article-title":"Altering the proclivity towards daptomycin resistance in methicillin-resistant Staphylococcus aureus using combination with other antibiotics","volume":"56","author":"Berti","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.clinthera.2015.04.008_bib30","article-title":"\u03b2-lactam combinations with daptomycin provide synergy against vancomycin-resistant Enterococcus faecalis and Enterococcus faecium","author":"Smith","year":"2015","journal-title":"J Antimicrob Chemother"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291815002325?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291815002325?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,9]],"date-time":"2024-06-09T00:17:33Z","timestamp":1717892253000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291815002325"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":30,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["S0149291815002325"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2015.04.008","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2015,7]]}}}